DE2031216A1
(de)
|
1969-06-19 |
1971-01-14 |
Citizen Watch Co Ltd , Tokio |
Tag und Datum Stellvorrichtung fur Uhren mit Kalender
|
US3691016A
(en)
|
1970-04-17 |
1972-09-12 |
Monsanto Co |
Process for the preparation of insoluble enzymes
|
US3940475A
(en)
|
1970-06-11 |
1976-02-24 |
Biological Developments, Inc. |
Radioimmune method of assaying quantitatively for a hapten
|
CA1023287A
(en)
|
1972-12-08 |
1977-12-27 |
Boehringer Mannheim G.M.B.H. |
Process for the preparation of carrier-bound proteins
|
US4195128A
(en)
|
1976-05-03 |
1980-03-25 |
Bayer Aktiengesellschaft |
Polymeric carrier bound ligands
|
US4330440A
(en)
|
1977-02-08 |
1982-05-18 |
Development Finance Corporation Of New Zealand |
Activated matrix and method of activation
|
CA1093991A
(en)
|
1977-02-17 |
1981-01-20 |
Hideo Hirohara |
Enzyme immobilization with pullulan gel
|
US4229537A
(en)
|
1978-02-09 |
1980-10-21 |
New York University |
Preparation of trichloro-s-triazine activated supports for coupling ligands
|
US4376110A
(en)
|
1980-08-04 |
1983-03-08 |
Hybritech, Incorporated |
Immunometric assays using monoclonal antibodies
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
DE3422247A1
(de)
|
1984-06-15 |
1985-12-19 |
Pfeifer & Langen, 5000 Köln |
Gluco-oligosaccharid-gemisch und verfahren zu seiner herstellung
|
US4737456A
(en)
|
1985-05-09 |
1988-04-12 |
Syntex (U.S.A.) Inc. |
Reducing interference in ligand-receptor binding assays
|
US5567610A
(en)
|
1986-09-04 |
1996-10-22 |
Bioinvent International Ab |
Method of producing human monoclonal antibodies and kit therefor
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
US5359037A
(en)
|
1988-09-12 |
1994-10-25 |
Yeda Research And Development Co. Ltd. |
Antibodies to TNF binding protein I
|
GB8823869D0
(en)
|
1988-10-12 |
1988-11-16 |
Medical Res Council |
Production of antibodies
|
AU643427B2
(en)
|
1988-10-31 |
1993-11-18 |
Immunex Corporation |
Interleukin-4 receptors
|
US4847745A
(en)
|
1988-11-16 |
1989-07-11 |
Sundstrand Corp. |
Three phase inverter power supply with balancing transformer
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
US5011778A
(en)
|
1989-05-23 |
1991-04-30 |
Otsuka Pharmaceutical Co., Ltd. |
Monoclonal antibodies directed to IL-1 activated endothelial cells and medicaments employing the monoclonal antibodies
|
EP0402226A1
(en)
|
1989-06-06 |
1990-12-12 |
Institut National De La Recherche Agronomique |
Transformation vectors for yeast yarrowia
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
SK635290A3
(en)
|
1989-12-20 |
1999-06-11 |
Schering Corp |
Polypeptide, subsequences thereof and their use
|
US5229275A
(en)
|
1990-04-26 |
1993-07-20 |
Akzo N.V. |
In-vitro method for producing antigen-specific human monoclonal antibodies
|
US5571894A
(en)
|
1991-02-05 |
1996-11-05 |
Ciba-Geigy Corporation |
Recombinant antibodies specific for a growth factor receptor
|
DE506574T1
(de)
|
1991-03-29 |
1994-11-17 |
Elf Sanofi, Paris |
Protein mit Cytokinaktivität, dafür kodierende rekombinante DNS, transformierte Zellen und Mikroorganismen.
|
IE922437A1
(en)
|
1991-07-25 |
1993-01-27 |
Idec Pharma Corp |
Recombinant antibodies for human therapy
|
US5994514A
(en)
|
1991-08-14 |
1999-11-30 |
Genentech, Inc. |
Immunoglobulin variants
|
US5965709A
(en)
|
1991-08-14 |
1999-10-12 |
Genentech, Inc. |
IgE antagonists
|
US6329509B1
(en)
|
1991-08-14 |
2001-12-11 |
Genentech, Inc. |
Anti-IgE antibodies
|
ES2136092T3
(es)
|
1991-09-23 |
1999-11-16 |
Medical Res Council |
Procedimientos para la produccion de anticuerpos humanizados.
|
US5587458A
(en)
|
1991-10-07 |
1996-12-24 |
Aronex Pharmaceuticals, Inc. |
Anti-erbB-2 antibodies, combinations thereof, and therapeutic and diagnostic uses thereof
|
ATE207080T1
(de)
|
1991-11-25 |
2001-11-15 |
Enzon Inc |
Multivalente antigen-bindende proteine
|
DE69333807T2
(de)
|
1992-02-06 |
2006-02-02 |
Chiron Corp., Emeryville |
Marker für krebs und biosynthetisches bindeprotein dafür
|
WO1993015766A1
(en)
|
1992-02-10 |
1993-08-19 |
Seragen, Inc. |
Desensitization to specific allergens
|
ATE244763T1
(de)
|
1992-02-11 |
2003-07-15 |
Cell Genesys Inc |
Erzielen von homozygotem durch zielgerichtete genetische ereignisse
|
US5573905A
(en)
|
1992-03-30 |
1996-11-12 |
The Scripps Research Institute |
Encoded combinatorial chemical libraries
|
AU680816B2
(en)
|
1992-05-15 |
1997-08-14 |
Quest International B.V. |
Cloning and expression of DNA encoding a ripening form of a polypeptide having phamnogalacturonase activity
|
US5397703A
(en)
|
1992-07-09 |
1995-03-14 |
Cetus Oncology Corporation |
Method for generation of antibodies to cell surface molecules
|
US5596072A
(en)
|
1992-08-21 |
1997-01-21 |
Schering Corporation |
Method of refolding human IL-13
|
AU5010793A
(en)
|
1992-08-21 |
1994-03-15 |
Schering Corporation |
Human interleukin-13
|
CA2149329C
(en)
|
1992-11-13 |
2008-07-15 |
Darrell R. Anderson |
Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
|
EP0604693A1
(en)
|
1992-12-29 |
1994-07-06 |
Schering-Plough |
Monoclonal antibodies against the human interleukin-4 receptor and hybridomas producing the same
|
PT866130E
(pt)
|
1993-05-17 |
2010-10-26 |
Genentech Inc |
Sialidase de células cho por tecnologia de adn recombinante
|
HU218610B
(hu)
|
1993-09-02 |
2000-10-28 |
Trustees Of Dartmouth College |
Eljárás antigén-specifikus T-sejt toleranciát kiváltó gyógyszerkészítmények előállítására
|
EP0659766A1
(en)
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
US5429746A
(en)
|
1994-02-22 |
1995-07-04 |
Smith Kline Beecham Corporation |
Antibody purification
|
US5534615A
(en)
|
1994-04-25 |
1996-07-09 |
Genentech, Inc. |
Cardiac hypertrophy factor and uses therefor
|
GB9415379D0
(en)
|
1994-07-29 |
1994-09-21 |
Smithkline Beecham Plc |
Novel compounds
|
US5705154A
(en)
|
1995-03-08 |
1998-01-06 |
Schering Corporation |
Humanized monoclonal antibodies against human interleukin-4
|
US6518061B1
(en)
|
1995-03-15 |
2003-02-11 |
The United States Of America As Represented By The Department Of Health And Human Services |
IL-13 receptor specific chimeric proteins and uses thereof
|
US6037453A
(en)
|
1995-03-15 |
2000-03-14 |
Genentech, Inc. |
Immunoglobulin variants
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
US6911530B1
(en)
|
1995-10-23 |
2005-06-28 |
Amrad Operations, Pty., Ltd. |
Haemopoietin receptor and genetic sequences encoding same
|
DE69638050D1
(de)
|
1995-10-23 |
2009-11-19 |
Zenyth Operations Pty Ltd |
Hemopoietin-rezeptor und dafür kodierende genetische sequenzen
|
FR2742156A1
(fr)
|
1995-12-06 |
1997-06-13 |
Sanofi Sa |
Polypeptide recepteur de l'il-13
|
DE122004000004I1
(de)
|
1996-02-09 |
2004-08-12 |
Abott Biotechnology Ltd |
Humane Antikörper welche an Humanen TNFalpha binden.
|
US7078494B1
(en)
|
1996-03-01 |
2006-07-18 |
Genetics Institute, Llc |
Antibodies to human IL-13bc and methods of their use in inhibiting IL-13 binding
|
US5710023A
(en)
|
1996-03-01 |
1998-01-20 |
Genetics Institute, Inc. |
IL-13 cytokine receptor chain
|
US6664227B1
(en)
|
1996-03-01 |
2003-12-16 |
Genetics Institute, Llc |
Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
|
AU6450196A
(en)
|
1996-06-12 |
1998-01-07 |
Human Genome Sciences, Inc. |
Hr-1 receptor
|
WO1998010638A1
(en)
|
1996-09-10 |
1998-03-19 |
Amrad Operations Pty. Ltd. |
Therapeutic molecules
|
SI0950067T1
(sl)
|
1996-11-27 |
2007-12-31 |
Genentech Inc |
Afinitetno čiščenje polipeptida na proteinskemA matriksu
|
US6743604B1
(en)
|
1996-12-13 |
2004-06-01 |
Smithkline Beecham Corporation |
Substances and their uses
|
GB9625899D0
(en)
|
1996-12-13 |
1997-01-29 |
Glaxo Group Ltd |
Substances and their uses
|
EE9900273A
(et)
|
1997-01-10 |
2000-02-15 |
Biogen, Incorporated |
Luupusnefriidi ravi CD40L-vastaste ühenditega
|
IL130908A0
(en)
|
1997-01-22 |
2001-01-28 |
Univ Texas |
Tissue-factor (tf) compositions for coagulation and tumor treatment
|
US6576232B1
(en)
|
1998-04-03 |
2003-06-10 |
The Penn State Research Foundation |
IL13 mutants
|
US6482403B1
(en)
|
1998-05-29 |
2002-11-19 |
Heska Corporation |
Caniney IL-13 immunoregulatory proteins and uses thereof
|
US6299875B1
(en)
|
1998-06-04 |
2001-10-09 |
Panacea Pharmaceuticals, Llc |
Methods to block IGE binding to cell surface receptors of mast cells
|
GB9820014D0
(en)
|
1998-09-14 |
1998-11-04 |
Cancer Res Campaign Tech |
Receptor antagonists and uses thereof
|
US7083950B2
(en)
|
1998-09-25 |
2006-08-01 |
Regeneron Pharmaceuticals, Inc. |
High affinity fusion proteins and therapeutic and diagnostic methods for use
|
DE19848026A1
(de)
|
1998-10-17 |
2000-04-20 |
Bayer Ag |
Verfahren zur Herstellung von Bis(4-hydroxyaryl)alkanen
|
IL127127A0
(en)
|
1998-11-18 |
1999-09-22 |
Peptor Ltd |
Small functional units of antibody heavy chain variable regions
|
US7553487B2
(en)
|
1998-12-14 |
2009-06-30 |
Genetics Institute, Llc |
Method and compositions for treating asthma
|
EP1141286B1
(en)
|
1998-12-14 |
2006-10-18 |
Genetics Institute, LLC |
Cytokine receptor chain
|
US6468528B1
(en)
|
1999-02-01 |
2002-10-22 |
Amgen Canada Inc. |
Materials and methods to inhibit Hodgkin and Reed Sternberg cell growth
|
CA2404763A1
(en)
|
1999-11-11 |
2001-05-17 |
Raj K. Puri |
Mutated il-13 molecules and their uses
|
US20100041039A1
(en)
|
2000-01-15 |
2010-02-18 |
Synageva Biopharma Corp. |
Analysis of nucleic acid obtained from nucleated red blood cells
|
EP1257584B2
(en)
|
2000-02-24 |
2013-03-06 |
Washington University St. Louis |
Humanized antibodies that sequester amyloid beta peptide
|
CA2401491C
(en)
|
2000-03-03 |
2011-07-05 |
Kyowa Hakko Kogyo Co., Ltd. |
Ccr4-binding antibody and diagnostic and therapeutic uses thereof
|
CN1323812A
(zh)
|
2000-05-16 |
2001-11-28 |
上海博德基因开发有限公司 |
一种新的多肽——人白细胞介素-13(il-13)受体11和编码这种多肽的多核苷酸
|
ES2311558T3
(es)
|
2000-10-20 |
2009-02-16 |
Genetics Institute, Inc. |
Uso de inhibidores de la il-13 para el tratamiento de tumores.
|
CA2424371A1
(en)
|
2000-10-20 |
2003-04-01 |
Chugai Seiyaku Kabushiki Kaisha |
Agonistic monoclonal antibody fragments
|
US7919467B2
(en)
|
2000-12-04 |
2011-04-05 |
Immunotope, Inc. |
Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
|
US8372954B2
(en)
|
2000-12-22 |
2013-02-12 |
National Research Council Of Canada |
Phage display libraries of human VH fragments
|
JP2005518336A
(ja)
|
2001-06-26 |
2005-06-23 |
イムクローン システムズ インコーポレイティド |
Vegf受容体に結合する二重特異性抗体
|
US20030023555A1
(en)
|
2001-07-26 |
2003-01-30 |
Cashworks, Inc. |
Method and system for providing financial services
|
DE60238503D1
(de)
|
2001-08-31 |
2011-01-13 |
Kyowa Hakko Kirin Co Ltd |
Mit humanem cdr gepfropfte antikörper und antikörperfragmente davon
|
US6908963B2
(en)
|
2001-10-09 |
2005-06-21 |
Nektar Therapeutics Al, Corporation |
Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
|
JP2005289809A
(ja)
|
2001-10-24 |
2005-10-20 |
Vlaams Interuniversitair Inst Voor Biotechnologie Vzw (Vib Vzw) |
突然変異重鎖抗体
|
EP1578912A4
(en)
|
2001-10-26 |
2007-12-26 |
Centocor Inc |
IL-13 MUTEIN PROTEINS, ANTIBODIES, COMPOSITIONS, METHODS AND USES
|
DE60230656D1
(de)
|
2001-11-07 |
2009-02-12 |
Cytos Biotechnology Ag |
Antigenraster welche il-5, il-13 oder eotaxin präshilen erkrankungen
|
JP4460302B2
(ja)
|
2002-02-05 |
2010-05-12 |
ジェネンテック インコーポレイテッド |
タンパク質精製法
|
AU2003223497A1
(en)
|
2002-04-05 |
2003-10-27 |
Centocor, Inc. |
Asthma-related anti-il-13 immunoglobulin derived proteins, compositions, methods and uses
|
US20040060102A1
(en)
|
2002-04-10 |
2004-04-01 |
Interspiro, Inc. |
Garments for biological, chemical and fire protection
|
PT1501369E
(pt)
|
2002-04-26 |
2015-09-21 |
Genentech Inc |
Purificação de proteínas com base na não afinidade
|
JP4689268B2
(ja)
|
2002-06-14 |
2011-05-25 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
Il−13およびnk−t細胞に関する、結腸炎を処置および予防する方法
|
AR041086A1
(es)
|
2002-08-30 |
2005-04-27 |
Glaxo Group Ltd |
Vacuna
|
WO2004019975A2
(en)
|
2002-08-30 |
2004-03-11 |
Glaxo Group Limited |
Il-14 vaccine for the treatment of asthma and atopic disorders
|
DE10303664A1
(de)
|
2003-01-23 |
2004-08-12 |
Nemod Immuntherapie Ag |
Erkennungsmoleküle zur Behandlung und Detektion von Tumoren
|
DE602004027348D1
(de)
|
2003-02-10 |
2010-07-08 |
Applied Molecular Evolution |
Abeta-bindende moleküle
|
US7157276B2
(en)
|
2003-06-20 |
2007-01-02 |
Biogen Idec Inc. |
Use of depth filtration in series with continuous centrifugation to clarify mammalian cell cultures
|
CN1845938B
(zh)
|
2003-06-30 |
2010-05-26 |
杜门蒂斯有限公司 |
多肽
|
GB0407315D0
(en)
|
2003-07-15 |
2004-05-05 |
Cambridge Antibody Tech |
Human antibody molecules
|
US7674459B2
(en)
*
|
2003-12-23 |
2010-03-09 |
Genentech, Inc. |
Treatment of cancer with a novel anti-IL13 monoclonal antibody
|
PL1704166T3
(pl)
|
2004-01-07 |
2015-10-30 |
Novartis Vaccines & Diagnostics Inc |
Przeciwciała monoklonalne swoiste względem M-CSF i ich zastosowania
|
US20080261249A1
(en)
|
2004-01-13 |
2008-10-23 |
Genentech, Inc |
Detecting and Quantifying Host Cell Proteins in Recombinant Protein Products
|
JP2008507253A
(ja)
|
2004-02-06 |
2008-03-13 |
ナイモックス コーポレーション |
ヒト化抗体
|
UA93181C2
(ru)
|
2004-02-23 |
2011-01-25 |
Эли Лилли Энд Компани |
СПОСОБ ПОЛУЧЕНИЯ АНТИТЕЛА K Ab ПЕПТИДУ
|
MXPA06012676A
(es)
|
2004-05-04 |
2007-04-02 |
Novo Nordisk Healthcare Ag |
Glucoformas o-enlazadas de polipeptidos y metodos de fabricacion de los mismos.
|
US20070037966A1
(en)
*
|
2004-05-04 |
2007-02-15 |
Novo Nordisk A/S |
Hydrophobic interaction chromatography purification of factor VII polypeptides
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
US7501121B2
(en)
|
2004-06-17 |
2009-03-10 |
Wyeth |
IL-13 binding agents
|
US20070048785A1
(en)
|
2004-06-09 |
2007-03-01 |
Lin Laura L |
Anti-IL-13 antibodies and complexes
|
TWI307630B
(en)
|
2004-07-01 |
2009-03-21 |
Glaxo Group Ltd |
Immunoglobulins
|
CA2584211C
(en)
|
2004-10-22 |
2014-07-08 |
Amgen Inc. |
Methods for refolding of recombinant antibodies
|
PL1838150T3
(pl)
|
2004-12-24 |
2014-03-31 |
Commw Scient Ind Res Org |
Kompozycje pestycydu i sposoby
|
SI1869065T1
(sl)
|
2005-03-11 |
2020-08-31 |
Wyeth Llc |
Postopek kromatografije z nizko porazdelitvijo
|
JP2008535913A
(ja)
|
2005-04-11 |
2008-09-04 |
メダレックス インコーポレーティッド |
タンパク質精製方法
|
US7825223B2
(en)
|
2005-06-17 |
2010-11-02 |
Janssen Alzheimer Immunotherapy |
Methods of purifying anti A β antibodies
|
JP3982545B2
(ja)
|
2005-09-22 |
2007-09-26 |
ダイキン工業株式会社 |
空気調和装置
|
GB2430883B
(en)
*
|
2005-09-30 |
2008-03-19 |
Cambridge Antibody Tech |
Interleukin-13 antibody composition
|
EP2532679B1
(en)
|
2005-10-21 |
2017-04-12 |
Novartis AG |
Human antibodies against il13 and therapeutic uses
|
KR101439828B1
(ko)
|
2005-11-30 |
2014-09-17 |
애브비 인코포레이티드 |
아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
|
US7667557B2
(en)
|
2005-12-06 |
2010-02-23 |
Tdk Corporation |
Thin-film bandpass filter using inductor-capacitor resonators
|
EP2361638B1
(en)
|
2005-12-12 |
2014-01-15 |
AC Immune S.A. |
A beta 1-42 specific monoclonal antibodies with therapeutic properties
|
PE20100748A1
(es)
|
2005-12-12 |
2010-11-12 |
Hoffmann La Roche |
Anticuerpo anti beta-4-amiloide que contiene asparagina glicosilada en la region variable de vh
|
DK1966244T3
(da)
|
2005-12-30 |
2012-04-23 |
Merck Patent Gmbh |
Anti-il-6-antistoffer der forebygger bindingen af il-6 sammensat af il-6ralfa til gp130
|
US7563875B2
(en)
|
2006-03-20 |
2009-07-21 |
The United States of America as represented by the Sercretary of the Army |
Recombinant chimeric human anti-botulinum antibodies
|
KR20150064254A
(ko)
*
|
2006-04-05 |
2015-06-10 |
애브비 바이오테크놀로지 리미티드 |
항체 정제
|
AU2007240624A1
(en)
|
2006-04-21 |
2007-11-01 |
Wyeth |
Methods for high-throughput screening of cell lines
|
TWI551607B
(zh)
|
2006-07-14 |
2016-10-01 |
Ac免疫公司 |
人類化抗體
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
EA015591B1
(ru)
|
2006-09-21 |
2011-10-31 |
Верениум Корпорейшн |
Фосфолипазы, кодирующие их нуклеиновые кислоты и способы их получения и применения
|
HUE033466T2
(en)
|
2006-10-02 |
2017-12-28 |
Ac Immune Sa |
Humanized antibody to beta-amyloid
|
AR063125A1
(es)
|
2006-10-04 |
2008-12-30 |
Genentech Inc |
Ensayo elisa para la deteccion de vegf
|
US8383350B1
(en)
|
2006-12-20 |
2013-02-26 |
Merck Sharp & Dohme Corp. |
Assay for detection of IL-10 antibodies
|
AR064826A1
(es)
|
2007-01-09 |
2009-04-29 |
Wyeth Corp |
Formulaciones de anticuerpos anti-il-13 y usos de los mismos. dispositivos, parche y jeringa
|
WO2008140455A1
(en)
|
2007-05-15 |
2008-11-20 |
Tanox, Inc. |
Treatment of radiation and chemo-therapy induced fibrosis using novel anti-il 13 monoclonal antibodies
|
CN104761641A
(zh)
|
2007-06-12 |
2015-07-08 |
Ac免疫有限公司 |
β淀粉样蛋白的人源化抗体
|
TWI516500B
(zh)
|
2007-06-12 |
2016-01-11 |
Ac免疫公司 |
抗β類澱粉蛋白單株抗體
|
US9433922B2
(en)
|
2007-08-14 |
2016-09-06 |
Emd Millipore Corporation |
Media for membrane ion exchange chromatography based on polymeric primary amines, sorption device containing that media, and chromatography scheme and purification method using the same
|
PT2238166E
(pt)
|
2007-10-05 |
2014-02-11 |
Genentech Inc |
Utilização do anticorpo anti-amilóide beta em doenças oculares
|
CN101883791B
(zh)
|
2007-10-05 |
2015-11-25 |
基因技术公司 |
人源化抗体
|
AU2008311366B2
(en)
|
2007-10-05 |
2015-03-12 |
Ac Immune S.A. |
Use of anti-amyloid beta antibody in ocular diseases
|
WO2009058769A1
(en)
*
|
2007-10-30 |
2009-05-07 |
Schering Corporation |
Purification of antibodies containing hydrophobic variants
|
US20110123530A1
(en)
|
2008-03-31 |
2011-05-26 |
Arron Joseph R |
Compositions and methods for treating and diagnosing asthma
|
WO2009131643A1
(en)
|
2008-04-21 |
2009-10-29 |
Monabio, Inc. |
Immunoassay for specific determination of s-adenosymethionine and analogs thereof in biological samples
|
JP2011519911A
(ja)
|
2008-05-05 |
2011-07-14 |
ノヴィミュンヌ エスア |
抗il17a/il−17f交差反応抗体及びその使用方法
|
CA2733223C
(en)
|
2008-08-05 |
2018-02-27 |
Toray Industries, Inc. |
Pharmaceutical composition comprising anti-caprin-1 antibody for treatment and prevention of cancers
|
US8790642B2
(en)
*
|
2008-08-29 |
2014-07-29 |
Genentech, Inc. |
Cross-reactive and bispecific anti-IL-17A/F antibodies
|
GB0818674D0
(en)
|
2008-10-10 |
2008-11-19 |
Univ Bath |
Materials and methods for resolving polyhydric species by electrophoresis
|
CN105111309A
(zh)
|
2008-10-20 |
2015-12-02 |
Abbvie公司 |
使用a蛋白亲和层析分离和纯化抗体
|
MX2011004198A
(es)
|
2008-10-20 |
2011-05-24 |
Abbott Lab |
Anticerpos que unen a il-12 y metodos para purificar los mismos.
|
BRPI0920572A8
(pt)
|
2008-10-20 |
2015-10-27 |
Abbott Lab |
Inativação viral durante a purificação dos anticorpos
|
EP2346901A1
(en)
|
2008-10-20 |
2011-07-27 |
Abbott Laboratories |
Antibodies that bind to il-18 and methods of purifying the same
|
CN101979404B
(zh)
|
2008-12-09 |
2015-01-14 |
厦门大学 |
H5亚型禽流感病毒保守中和表位模拟肽及其用途
|
FR2944448B1
(fr)
|
2008-12-23 |
2012-01-13 |
Adocia |
Composition pharmaceutique stable comprenant au moins un anticorps monodonal et au moins un polysacharide amphiphile comprenant des substituants derives d'alcools hydrofobes ou d'amines hydrophobes.
|
WO2011010940A1
(en)
|
2009-07-19 |
2011-01-27 |
Serguei Zavtrak |
Solar electric power generator
|
HUE038451T2
(hu)
|
2009-08-06 |
2018-10-29 |
Hoffmann La Roche |
Eljárás vírus eltávolításának javítására fehérjetisztítás során
|
CA3067609A1
(en)
|
2009-09-03 |
2011-03-10 |
Merck Sharp & Dohme Corp. |
Anti-gitr antibodies
|
UA109884C2
(uk)
|
2009-10-16 |
2015-10-26 |
|
Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування
|
HUE053489T2
(hu)
*
|
2009-10-20 |
2021-06-28 |
Abbvie Inc |
Az anti-il-13 antitestek izolálása és tisztítása a protein A affinitás kromatográviával
|
DK3342786T3
(en)
|
2010-01-29 |
2021-09-27 |
Chugai Pharmaceutical Co Ltd |
Anti-dll3-antistof
|
PE20170779A1
(es)
|
2010-03-04 |
2017-07-04 |
Macrogenics Inc |
Anticuerpos reactivos con b7-h3, fragmentos inmunologicamente activos de los mismos y usos de los mismos
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
EP2569013B1
(en)
|
2010-05-14 |
2016-11-23 |
The Board of Trustees of the Leland Stanford Junior University |
Humanized and chimeric monoclonal antibodies to cd47
|
NZ702053A
(en)
|
2010-05-17 |
2016-01-29 |
Livtech Inc |
Anti-human trop-2 antibody having antitumor activity in vivo
|
BR112012029904A2
(pt)
|
2010-05-25 |
2017-08-08 |
Genentech Inc |
métodos de purificação de polipeptídeos
|
CA2804399A1
(en)
|
2010-07-06 |
2012-01-12 |
Aveo Pharmaceuticals, Inc. |
Anti-ron antibodies
|
RU2607368C2
(ru)
|
2010-07-30 |
2017-01-10 |
Ац Иммуне С.А. |
Безопасные и функциональные гуманизированные антитела
|
CN103313727B
(zh)
|
2010-09-29 |
2015-07-22 |
弗·哈夫曼-拉罗切有限公司 |
抗体组合物及使用方法
|
BR112013013083A2
(pt)
*
|
2010-11-30 |
2016-12-13 |
Genentech Inc |
métodos para transportar um composto, para aumentar exposição do cns a um composto, para diminuir a depuração de um composto, para aumentar a retenção no cns de um composto, para otimizar a farmacocinética, para tratar um distúrbio neurológico em um mamífero, para desenvolver um anticorpo, anticorpo, fragmento de anticorpo, anticorpo multiespecífico e uso de um anticorpo
|
MX352789B
(es)
|
2010-12-16 |
2017-12-08 |
Genentech Inc |
Anticuerpo anti-il-13 para usarse en tratar un asma o un trastorno respiratorio.
|
WO2012145493A1
(en)
|
2011-04-20 |
2012-10-26 |
Amplimmune, Inc. |
Antibodies and other molecules that bind b7-h1 and pd-1
|
DK3091029T3
(da)
*
|
2011-10-31 |
2023-01-30 |
Hoffmann La Roche |
Anti-IL13-antistofformuleringer
|
US20140288278A1
(en)
*
|
2011-10-31 |
2014-09-25 |
Joseph Nti-Gyabaah |
Chromatography process for resolving heterogeneous antibody aggregates
|
BR112014012005A2
(pt)
*
|
2011-11-21 |
2017-12-19 |
Genentech Inc |
composições, métodos, formulação farmacêutica e artigo
|
PT2791176T
(pt)
|
2011-12-15 |
2018-11-05 |
Prestige Biopharma Pte Ltd |
Um método de purificação de anticorpos
|
WO2013120497A1
(en)
*
|
2012-02-15 |
2013-08-22 |
Curevac Gmbh |
Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein
|
NZ629178A
(en)
|
2012-02-29 |
2016-09-30 |
Gilead Biologics Inc |
Antibodies to matrix metalloproteinase 9
|
KR102373930B1
(ko)
*
|
2013-09-13 |
2022-03-11 |
제넨테크, 인크. |
정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물
|
JP6546178B2
(ja)
*
|
2013-09-13 |
2019-07-17 |
ジェネンテック, インコーポレイテッド |
細胞株中の宿主細胞タンパク質及び組換えポリペプチド産物を検出及び定量化するための組成物並びに方法
|